ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 233 filers reported holding ROYALTY PHARMA PLC in Q3 2021. The put-call ratio across all filers is 0.36 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,750 | 0.0% | 89,456 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $2,750 | -20.3% | 89,456 | -6.6% | 0.01% | -35.3% |
| Q1 2023 | $3,450 | +170.8% | 95,769 | +202.1% | 0.02% | +142.9% |
| Q4 2022 | $1,274 | -99.9% | 31,697 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $1,274,000 | -1.5% | 31,697 | +3.0% | 0.01% | 0.0% |
| Q2 2022 | $1,294,000 | -28.1% | 30,783 | -33.4% | 0.01% | 0.0% |
| Q1 2022 | $1,800,000 | +44.1% | 46,192 | +47.3% | 0.01% | +75.0% |
| Q4 2021 | $1,249,000 | +19.8% | 31,351 | +8.6% | 0.00% | 0.0% |
| Q3 2021 | $1,043,000 | -57.8% | 28,858 | -52.1% | 0.00% | 0.0% |
| Q2 2021 | $2,470,000 | -10.4% | 60,258 | -4.7% | 0.00% | -33.3% |
| Q1 2021 | $2,756,000 | -94.0% | 63,204 | -62.1% | 0.01% | -70.0% |
| Q4 2020 | $45,906,000 | – | 166,766 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |